Skip to main content
Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: A novel scoring system based on common laboratory tests predicts the efficacy of TNF-inhibitor and IL-6 targeted therapy in patients with rheumatoid arthritis: a retrospective, multicenter observational study

Fig. 2

Verification test of the scoring system in 86 patients from Iizuka Hospital. Patients with 2 or more points had a significantly increased rate of good response and a lower rate of non-response to tocilizumab (TCZ) treatment compared with TNF inhibitor (TNF-i) treatment. This tendency became remarkable in patients with 3 or more points. In contrast, patients with 1 or fewer points had a significantly increased rate of good response to TNF-i treatment compared with TCZ treatment. N.S. not significant

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us